Monarch Private Capital, (“Monarch”) and Generate Capital, PBC (“Generate”) today announced the closing of a 104 megawatt (MW) energy investment portfolio.

TAMPA, Fla. — Generac, a leading manufacturer of generators, expects residential demand to continue rising in storm impacted areas, and its hiring hundreds of employees as a result. Tampa Bay area ...

"In theory, this protects ordinary ratepayers from shouldering the cost of industrial-scale electricity demand. In practice, ...

Generac settles construction-site explosion suit for $206M Generac stock spikes on potential for data center products Generac ...

Rendering isn’t always immediate or complete. Learn where no-JavaScript fallbacks still protect critical content, links, and ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Katelyn is a reporter with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

I recently saw a tweet showing how Google has acquired companies over the years and built products around them. Here is the link to the tweet if you want. Now, Google made another announcement: Google ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...